REPORT ID 5268

Asia-Pacific Weight Loss Drugs Market Report 2017

Publish Date
20-Dec-17
Pages
111
Format
Electronic (PDF)

In this report, the Asia-Pacific Weight Loss Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Weight Loss Drugs for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Weight Loss Drugs market competition by top manufacturers/players, with Weight Loss Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Roche
    GSK group
    Teva
    Sandoz(Novartis)
    STADA-VN J.V.Co., Ltd
    Hexal AG
    National Company For Pharmaceutical Industry
    Lunan Pharmaceutical Group Corporation
    Zein Pharmaceutical
    Hisun
    Taj Pharmaceuticals Ltd
    Kabir Life Sciences & Research
    Dm Pharma
    China Zhongshan Pharm

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Liauid
    Tablets

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Weight-reducing Aid
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Weight Loss Drugs Market Report 2017
1 Weight Loss Drugs Overview
    1.1 Product Overview and Scope of Weight Loss Drugs
    1.2 Classification of Weight Loss Drugs by Product Category
        1.2.1 Asia-Pacific Weight Loss Drugs Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Weight Loss Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Liauid
        1.2.4 Tablets
    1.3 Asia-Pacific Weight Loss Drugs Market by Application/End Users
        1.3.1 Asia-Pacific Weight Loss Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Weight-reducing Aid
        1.3.3 Other
    1.4 Asia-Pacific Weight Loss Drugs Market by Region
        1.4.1 Asia-Pacific Weight Loss Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Weight Loss Drugs (2012-2022)
        1.5.1 Asia-Pacific Weight Loss Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Weight Loss Drugs Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Weight Loss Drugs Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Weight Loss Drugs Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Weight Loss Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Weight Loss Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Weight Loss Drugs (Volume and Value) by Type
        2.2.1 Asia-Pacific Weight Loss Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Weight Loss Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Weight Loss Drugs (Volume) by Application
    2.4 Asia-Pacific Weight Loss Drugs (Volume and Value) by Region
        2.4.1 Asia-Pacific Weight Loss Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Weight Loss Drugs Revenue and Market Share by Region (2012-2017)

3 China Weight Loss Drugs (Volume, Value and Sales Price)
    3.1 China Weight Loss Drugs Sales and Value (2012-2017)
        3.1.1 China Weight Loss Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 China Weight Loss Drugs Sales Price Trend (2012-2017)
    3.2 China Weight Loss Drugs Sales Volume and Market Share by Type
    3.3 China Weight Loss Drugs Sales Volume and Market Share by Application

4 Japan Weight Loss Drugs (Volume, Value and Sales Price)
    4.1 Japan Weight Loss Drugs Sales and Value (2012-2017)
        4.1.1 Japan Weight Loss Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Weight Loss Drugs Sales Price Trend (2012-2017)
    4.2 Japan Weight Loss Drugs Sales Volume and Market Share by Type
    4.3 Japan Weight Loss Drugs Sales Volume and Market Share by Application

5 South Korea Weight Loss Drugs (Volume, Value and Sales Price)
    5.1 South Korea Weight Loss Drugs Sales and Value (2012-2017)
        5.1.1 South Korea Weight Loss Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Weight Loss Drugs Sales Price Trend (2012-2017)
    5.2 South Korea Weight Loss Drugs Sales Volume and Market Share by Type
    5.3 South Korea Weight Loss Drugs Sales Volume and Market Share by Application

6 Taiwan Weight Loss Drugs (Volume, Value and Sales Price)
    6.1 Taiwan Weight Loss Drugs Sales and Value (2012-2017)
        6.1.1 Taiwan Weight Loss Drugs Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Weight Loss Drugs Sales Price Trend (2012-2017)
    6.2 Taiwan Weight Loss Drugs Sales Volume and Market Share by Type
    6.3 Taiwan Weight Loss Drugs Sales Volume and Market Share by Application

7 India Weight Loss Drugs (Volume, Value and Sales Price)
    7.1 India Weight Loss Drugs Sales and Value (2012-2017)
        7.1.1 India Weight Loss Drugs Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 India Weight Loss Drugs Sales Price Trend (2012-2017)
    7.2 India Weight Loss Drugs Sales Volume and Market Share by Type
    7.3 India Weight Loss Drugs Sales Volume and Market Share by Application

8 Southeast Asia Weight Loss Drugs (Volume, Value and Sales Price)
    8.1 Southeast Asia Weight Loss Drugs Sales and Value (2012-2017)
        8.1.1 Southeast Asia Weight Loss Drugs Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Weight Loss Drugs Sales Price Trend (2012-2017)
    8.2 Southeast Asia Weight Loss Drugs Sales Volume and Market Share by Type
    8.3 Southeast Asia Weight Loss Drugs Sales Volume and Market Share by Application

9 Australia Weight Loss Drugs (Volume, Value and Sales Price)
    9.1 Australia Weight Loss Drugs Sales and Value (2012-2017)
        9.1.1 Australia Weight Loss Drugs Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Weight Loss Drugs Sales Price Trend (2012-2017)
    9.2 Australia Weight Loss Drugs Sales Volume and Market Share by Type
    9.3 Australia Weight Loss Drugs Sales Volume and Market Share by Application

10 Asia-Pacific Weight Loss Drugs Players/Suppliers Profiles and Sales Data
    10.1 Roche
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Weight Loss Drugs Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Roche Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 GSK group
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Weight Loss Drugs Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 GSK group Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Teva
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Weight Loss Drugs Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Teva Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Sandoz(Novartis)
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Weight Loss Drugs Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Sandoz(Novartis) Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 STADA-VN J.V.Co., Ltd
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Weight Loss Drugs Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Hexal AG
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Weight Loss Drugs Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Hexal AG Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 National Company For Pharmaceutical Industry
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Weight Loss Drugs Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 National Company For Pharmaceutical Industry Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Lunan Pharmaceutical Group Corporation
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Weight Loss Drugs Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Zein Pharmaceutical
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Weight Loss Drugs Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Zein Pharmaceutical Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Hisun
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Weight Loss Drugs Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Hisun Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Taj Pharmaceuticals Ltd
    10.12 Kabir Life Sciences & Research
    10.13 Dm Pharma
    10.14 China Zhongshan Pharm

11 Weight Loss Drugs Manufacturing Cost Analysis
    11.1 Weight Loss Drugs Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Weight Loss Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Weight Loss Drugs Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Weight Loss Drugs Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Weight Loss Drugs Market Forecast (2017-2022)
    15.1 Asia-Pacific Weight Loss Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Weight Loss Drugs Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Weight Loss Drugs Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Weight Loss Drugs Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Weight Loss Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Weight Loss Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Weight Loss Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Weight Loss Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Weight Loss Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Weight Loss Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Weight Loss Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Weight Loss Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Weight Loss Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Weight Loss Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Weight Loss Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Weight Loss Drugs Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Weight Loss Drugs Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Weight Loss Drugs Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Weight Loss Drugs Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer